Physiomics Plc (LON:PYC – Get Free Report)’s stock price was down 7.4% during mid-day trading on Monday . The company traded as low as GBX 1.02 ($0.01) and last traded at GBX 1.02 ($0.01). Approximately 686,122 shares traded hands during trading, a decline of 92% from the average daily volume of 8,663,399 shares. The stock had previously closed at GBX 1.11 ($0.01).
Physiomics Stock Performance
The company has a market capitalization of £2.29 million, a PE ratio of -13.83 and a beta of 1.69. The company’s fifty day moving average is GBX 0.78 and its 200-day moving average is GBX 0.72.
Insider Transactions at Physiomics
In other Physiomics news, insider Peter Sargent bought 459,090 shares of the business’s stock in a transaction that occurred on Thursday, November 7th. The stock was purchased at an average price of GBX 1 ($0.01) per share, for a total transaction of £4,590.90 ($5,712.21). Corporate insiders own 4.18% of the company’s stock.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Read More
- Five stocks we like better than Physiomics
- Investing in the High PE Growth Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- What Does the Future Hold for Eli Lilly?
- Quiet Period Expirations Explained
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
